CD274 and small cell lung carcinoma: A meta-analysis of 27 studies involving 2792 SCLC patients found that PD-L1 expression in tumor tissue was approximately 22%–26%, with no significant correlation to overall survival (HR = 0.86, 95% CI 0.49–1.50, p = 0.588).